866775-16-8

Basic information

• Product Name: 3-Nitro-5-trifluoromethyl-pyridine-2-carbonitrile
• Synonyms: 3-Nitro-5-trifluoromethyl-pyridine-2-carbonitrile;2-Pyridinecarbonitrile, 3-nitro-5-(trifluoromethyl)-
• CAS NO: 866775-16-8
• Molecular Formula: C₇H₂F₃N₃O₂
• Molecular Weight: 217.11
• Mol File: 866775-16-8.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 313.3±42.0 °C(Predicted)
• Appearance: /
• Density: 1.58±0.1 g/cm3(Predicted)
• PKA: -6.78±0.20(Predicted)
• CAS DataBase Reference: 3-Nitro-5-trifluoromethyl-pyridine-2-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Nitro-5-trifluoromethyl-pyridine-2-carbonitrile(866775-16-8)
• EPA Substance Registry System: 3-Nitro-5-trifluoromethyl-pyridine-2-carbonitrile(866775-16-8)

Safety Data

• Hazardous Substances Data: 866775-16-8(Hazardous Substances Data)

Usage

General Description

3-nitro-5-trifluoromethyl-pyridine-2-carbonitrile is a chemical compound with the formula C7H2F3N3O2. It is a yellow crystalline solid with a molecular weight of 215.11 g/mol. 3-nitro-5-trifluoromethyl-pyridine-2-carbonitrile is often used as a building block in the synthesis of various pharmaceuticals and agrochemicals. It is also used in medicinal chemistry research as a starting material for the development of novel drug candidates. Additionally, 3-nitro-5-trifluoromethyl-pyridine-2-carbonitrile is utilized in the production of dyes, pigments, and other specialty chemicals. It is important to handle this compound with care as it possesses potential health hazards and should be used in a well-ventilated area and proper personal protective equipment should be worn.

Upstream product

• 544-92-3 copper(I) cyanide 
• 72587-15-6 2-chloro-3-nitro-5-(trifluoromethyl)pyridine 
• 1214336-90-9 3-amino-6-(2,6-difluorophenyl)-5-trifluoromethyl-2-pyridinecarboxylicacid 
• 33252-64-1 3-nitro-5-trifluoromethylpyridin-2-ol 

Downstream Products

• 866775-17-9 3-amino-5-trifluoromethyl-pyridine-2-carboxylic acid methyl ester 
• 866775-18-0 3-amino-6-bromo-5-trifluoromethyl-pyridine-2-carboxylic acid methyl ester 
• 1334546-83-6 3-amino-6-(2,4-dichlorophenyl)-5-trifluoromethylpyridine-2-carboxylic acid 
• 1214370-77-0 3-amino-5-trifluoromethylpyridine-2-carboxylic acid 
• 1334547-21-5 3-amino-6-(4-fluorophenyl)-5-trifluoromethylpyridine-2-carboxylic acid 
• 1334547-23-7 3-amino-6-(2,4-dichlorophenyl)-5-trifluoromethylpyridine-2-carboxylic acid methyl ester 
• 1211515-30-8 3-amino-5-(trifluoromethyl)picolinonitrile 
• 1334546-80-3 3-amino-6-(4-fluorophenyl)-5-trifluoromethylpyridine-2-carboxylic acid ((S)-3,3,3-trifluoro-2-hydroxy-2-methylpropyl)amide 
• 1427262-61-0 3-amino-6-bromo-N'-(2-phenylacetyl)-5-(trifluoromethyl)picolinohydrazide 
• 1427262-60-9 2-(5-benzyl-1,3,4-oxadiazol-2-yl)-6-bromo-5-(trifluoromethyl)pyridin-3-amine 
• 1427262-81-4 (R)-benzyl 2-(2-(3-amino-6-bromo-5-(trifluoromethyl)picolinoyl)hydrazinyl)-2-oxo-1-phenylethylcarbamate 
• 1427262-83-6 (R)-benzyl (5-(3-amino-6-bromo-5-(trifluoromethyl)pyridin-2-yl)-1,3,4-oxadiazol-2-yl)(phenyl)methylcarbamate 
• 1427262-80-3 (R)-2-(5-(amino(phenyl)methyl)-1,3,4-oxadiazol-2-yl)-6-bromo-5-(trifluoromethyl)pyridin-3-amine 
• 1427400-35-8 methyl 3-amino-6-(4-fluorophenyl)-5-(trifluoromethyl)picolinate 

Relevant articles and documents

Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease

Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) ion channel are established as the primary causative factor in the devastating lung disease cystic fibrosis (CF). More recently, cigarette smoke exposure has been shown to be asso

Pyridine derivative PIM kinase inhibitor and preparation method therefor and application thereof in pharmacy

The present invention provides a PIM kinase inhibitor and a preparation method therefor and an application thereof. The PIM kinase inhibitor is a compound with the structural formula shown in the formula I (the formula is shown in description). The present invention further provides a stereoisomer, a tautomer and pharmaceutical salt of the compound shown in the formula I. According to the present invention, the compound has an obvious inhibition effect on kinase activity. The PIM kinase inhibitor can be used for preparing drugs for curing or preventing cancer, autoimmune diseases, allergic reaction diseases or organ transplant rejection resistance and the like, and the PIM kinase inhibitor has relatively large value in clinical application.

FUSED MULTI-CYCLIC SULFONE COMPOUNDS AS INHIBITORS OF BETA-SECRETASE AND METHODS OF USE THEREOF

The present invention provides a new class of compounds useful for the modulation of beta-secretase enzyme (BACE) activity. The compounds have a general Formula I: wherein variables A5, A6, A8, R1, R2, R3, R7, X, Y, n and o of Formula I, independently, are defined herein. The invention also provides pharmaceutical compositions comprising the compounds, and corresponding uses of the compounds and compositions for treatment of disorders and/or conditions related to A-beta plaque formation and deposition, resulting from the biological activity of BACE. Such BACE mediated disorders include, for example, Alzheimer's Disease, cognitive deficits, cognitive impairments, schizophrenia and other central nervous system conditions. The invention further provides compounds of Formula II and sub-formula embodiments thereof, compounds of Formula III, intermediates and processes and methods useful for the preparation of compounds of Formulas I-III, and sub-Formulas thereof.